16-Staff Bio-Latham Steve-667x667

Steve Latham

This news immediately took me back to one of the most amazing things I have ever witnessed — open heart surgery on an infant. As part of our project, I observed this incredible and delicate feat of medical care along with Kent Kallsen, Design Concepts vice president of engineering. We both came away from this emotional experience highly motivated to do whatever we could to help Dr. Hopkin’s and his team improve and save the lives of these tiny patients.
Dr. Hopkins and his team at the Cardiac Regenerative Surgery Research Labs at Children’s Mercy Hospital, Kansas City are pioneering a technique for growing semi-autologous heart valves for replacement surgeries. In simple terms, this means a child could receive a heart valve that grows with them throughout the course of their lives. This has the potential to change the course of treatment to a single cardiac surgical event from the more typical course of treatment that involves many open heart surgeries over the course of childhood to replace valves no longer large enough for a growing heart.
A couple years ago, the team approached Design Concepts about developing the BioReactor to help them research and ultimately commercialize their process. The challenge was to provide a set of equipment that allowed three distinct stages: stripping the donor valve of all tissue, allowing the resulting scaffold to wick stem cells under controlled conditions, and finally placing the valve into a chamber to provide tension, pulsing action and a continuous stream of nutrients and other media to encourage full seeding.
 Our design approach focused on keeping things simple. Our view throughout the project was to simply “get the job done” and make sure the equipment did not hinder or confuse any of the steps. The magic is in the medicine and the equipment should do the few things it needs to do, and do them well.

The largest architectural hurdle was to design the last two stages such that the valve would experience as little manipulation as possible when moving from its soaking container to its pulsation chamber. We designed a cap assembly that holds the valve and fits both chambers allowing movement from one step of the process to the other with minimal touching of the valve. This cap utilizes a drive screw and seals that allow for adjustment within each of the two chambers without breaking sterility. The soaking chamber required precise adjustment to dip the edge of the valve into the bone marrow sample. The pulsation chamber required that we “grab” the valve (using a magnet and a ferrous component temporarily sewn to the valve) and provide tension by adjusting the drive screw until the tissue was stretched. The design of this cap assembly allows full adjustment of valves from newborn to adult sizes without the physical envelope of the containers changing, making it possible to utilize standard laboratory ovens and avoid tipping and catching hazards along the way.
In the end we worked with Children's Mercy to procure production tooling and molded parts, resulting in a short production run of 250 full assemblies. These production parts have been used to treat and grow heart valves for implantation in sheep and primates. Taking advantage of the overall design and tune-ability of the BioReactor, they have been able to significantly reduce the time it will take to seed donor valves with the recipient’s stem cells and prepare the valves for implantation and growth within the patient. This development is another key step on the way to providing viable, growing valves to children within a window of only days from bone marrow harvest to completed implantation.
We hope to continue our support of this project and help Dr. Hopkins and his team bring a technology to children who will greatly benefit from advances in treatment. His team is doing amazing work and I look forward to seeing where this technology goes in the years to come.<a href="http://www.childrensmercy.org/Clinics_and_Services/Clinics_and_Departments/Heart_Center/News_and_Features/Ushering_in_a_New_Era_of_Regenerative_Congenital_Cardiac_Surgery_for_Children/" target="_blank"> Learn more about this exciting project.</a>

Engineering

Electrical & Software Engineering

Mechanical Engineering

We recently heard from a valued client of ours and learned some great news. Using the BioReactor we helped design and manufacture, Dr. Richard Hopkins and his team at Children's Mercy Hospital, Kansas City, have been able to reach a major milestone in their development of a process for replacing heart valves in children.

We've been developing medical devices to meet rigorous standards for 55 years.

Services Page: Medical Devices (text only)

This news immediately took me back to one of the most amazing things I have ever witnessed — open heart surgery on an infant. As part of our project, I observed this incredible and delicate feat of medical care along with Kent Kallsen, Design Concepts vice president of engineering. We both came away from this emotional experience highly motivated to do whatever we could to help Dr. Hopkin’s and his team improve and save the lives of these tiny patients.
Dr. Hopkins and his team at the Cardiac Regenerative Surgery Research Labs at Children’s Mercy Hospital, Kansas City are pioneering a technique for growing semi-autologous heart valves for replacement surgeries. In simple terms, this means a child could receive a heart valve that grows with them throughout the course of their lives. This has the potential to change the course of treatment to a single cardiac surgical event from the more typical course of treatment that involves many open heart surgeries over the course of childhood to replace valves no longer large enough for a growing heart.
A couple years ago, the team approached Design Concepts about developing the BioReactor to help them research and ultimately commercialize their process. The challenge was to provide a set of equipment that allowed three distinct stages: stripping the donor valve of all tissue, allowing the resulting scaffold to wick stem cells under controlled conditions, and finally placing the valve into a chamber to provide tension, pulsing action and a continuous stream of nutrients and other media to encourage full seeding.
Our design approach focused on keeping things simple. Our view throughout the project was to simply “get the job done” and make sure the equipment did not hinder or confuse any of the steps. The magic is in the medicine and the equipment should do the few things it needs to do, and do them well.
The largest architectural hurdle was to design the last two stages such that the valve would experience as little manipulation as possible when moving from its soaking container to its pulsation chamber. We designed a cap assembly that holds the valve and fits both chambers allowing movement from one step of the process to the other with minimal touching of the valve. This cap utilizes a drive screw and seals that allow for adjustment within each of the two chambers without breaking sterility. The soaking chamber required precise adjustment to dip the edge of the valve into the bone marrow sample. The pulsation chamber required that we “grab” the valve (using a magnet and a ferrous component temporarily sewn to the valve) and provide tension by adjusting the drive screw until the tissue was stretched. The design of this cap assembly allows full adjustment of valves from newborn to adult sizes without the physical envelope of the containers changing, making it possible to utilize standard laboratory ovens and avoid tipping and catching hazards along the way.
In the end we worked with Children's Mercy to procure production tooling and molded parts, resulting in a short production run of 250 full assemblies.&nbsp;

Let Delve's multidisciplinary medical device experts assist you with product innovation for Class II and Class III devices.

Sector Page: Medical Devices

These production parts have been used to treat and grow heart valves for implantation in sheep and primates. Taking advantage of the overall design and tune-ability of the BioReactor, they have been able to significantly reduce the time it will take to seed donor valves with the recipient’s stem cells and prepare the valves for implantation and growth within the patient. This development is another key step on the way to providing viable, growing valves to children within a window of only days from bone marrow harvest to completed implantation.
We hope to continue our support of this project and help Dr. Hopkins and his team bring a technology to children who will greatly benefit from advances in treatment. His team is doing amazing work and I look forward to seeing where this technology goes in the years to come.<a href="http://www.childrensmercy.org/Clinics_and_Services/Clinics_and_Departments/Heart_Center/News_and_Features/Ushering_in_a_New_Era_of_Regenerative_Congenital_Cardiac_Surgery_for_Children/" target="_blank"> Learn more about this exciting project.</a>

Learn more about&nbsp;<a href="https://www.delve.com/medical-devices" target="_blank">Delve Product Development Services for Medical Devices.</a>

SEO Text: Medical Devices Sector

12-Article Latham-St Marys-Hero 1-2372x1334

Using the BioReactor we helped design and manufacture, Dr. Hopkins' team have reached a milestone in developing a process for replacing pediatric heart valves.

Contact Us | General (Let's build something together)

Medical Devices

Home

Insights

BioReactor Could Have Big Impact on Saving Small Hearts

Breadcrumbs

A full-service product design and strategic innovation consultancy.

Delve

Using the BioReactor we helped design and manufacture, Dr. Hopkins' team have reached a milestone in developing a process for replacing pediatric heart valves.

Using the BioReactor we helped design and manufacture, Dr. Hopkins' team have reached a milestone in developing a process for replacing pediatric heart…

description

generator

kSwNn6qD4B-4HloWnWMUBWQNpBx2_mPi3nMqgsh6ato

google-site-verification

helped, reached, milestone, developing, process, replacing, pediatric, bioreactor, design, team, heart, using, manufacture, hopkins, valves

keywords

https://cms.delve.com/assets/images/_1200x630_crop_center-center_82_none/12-Article_Latham-St_Marys-Hero_1-2372x1334.jpg?mtime=1598897947

https://linkedin.com/company/delvedesign/

https://www.delve.com/insights/bioreactor-could-have-big-impact-on-saving-small-hearts

referrer

robots

twitter:card

twitter:creator

twitter:description

https://cms.delve.com/assets/images/_800x418_crop_center-center_82_none/12-Article_Latham-St_Marys-Hero_1-2372x1334.jpg?mtime=1598897947

twitter:image

twitter:image:alt

twitter:image:height

twitter:image:width

twitter:site

twitter:title

{"title":{"title":"BioReactor Could Have Big Impact on Saving Small Hearts | Delve"}}

Get Inspired

Privacy Policy

FCOI Policy

Services

Case Studies

Testimonials

What We Do

About Us

Our People

Join Our Team

Careers

Newsroom

Who We Are

Boston

Madison

Philadelphia

San Francisco

Our Studios

Partner with Delve

Contact Us

Sign Up for the Delve Newsletter

Newsletter

Contact

Vamsee Pamula, Founder &amp; President, Baebies

Read informative articles from Delve's team of experts. Discover innovative strategies and insights about product design, engineering, and development.

Delve Insights: Product Innovation & Development Blog

innovation, product, design, advice, development

https://cms.delve.com/assets/images/_1200x630_crop_center-center_82_none/Delve_titlecard.png?mtime=1654035558

https://cms.delve.com/assets/images/_800x418_crop_center-center_82_none/Delve_titlecard.png?mtime=1654035558

BioReactor Could Have Big Impact on Saving Small Hearts

BioReactor Could Have Big Impact on Saving Small Hearts

Related Insights